Site gating for urine
Urinary-only agents are graded when the specimen is urine and marked not applicable for every other site. The reverse also holds: agents that don't achieve useful urinary concentrations aren't offered for a urinary source.
Organism rules that change the urinary grid
- Proteus mirabilis / vulgaris are intrinsically resistant to nitrofurantoin and the tetracyclines, so a common first-line cystitis agent is removed for them.
- Klebsiella is intrinsically resistant to ampicillin.
- Pseudomonas aeruginosa removes most oral options, including TMP-SMX.
- Enterococcus is intrinsically resistant to cephalosporins.
Genes that matter most in urine
Beta-lactamase genes (CTX-M, KPC / SHV, AmpC), plasmid quinolone resistance (qnrA / qnrB, qnrS) and folate-pathway genes (dfrA, sul1 / sul2) move the common oral options. CORE-ABR applies each only to the organisms known to carry it.
Molecular detection does not replace urine culture or phenotypic susceptibility testing. Absence of a detected resistance gene does not establish susceptibility.
Pathogens on UTI panels
Resistance genes relevant to UTI
Decision support only. The treating clinician decides. Molecular genotype does not replace phenotypic susceptibility testing, culture, or public-health reporting. Absence of a detected resistance gene does not establish susceptibility. Organism targets vary by panel; CORE-ABR is configured to the assay each laboratory runs.